Philippines to Implement Graphic Health Warnings on E-cigarettes, Violators Face up to 6 Years in Prison

Regulations by 2FIRSTS.ai
Apr.25.2024
Philippines to Implement Graphic Health Warnings on E-cigarettes, Violators Face up to 6 Years in Prison
Philippines to require graphic health warnings on e-cigarettes and vaping products starting May 2024, with hefty fines for non-compliance.

According to a report by Philippine media outlet Philstar on April 25th, the Department of Health in the Philippines has announced that e-cigarettes or vaping products in the Philippines market will soon be required to display graphic health warnings, similar to tobacco products.

 

The Ministry of Health has released the first set of graphic health warning templates (GHW) for use with nicotine aerosols, tobacco products without nicotine, and new tobacco products.

 

The Ministry of Health announced in a bulletin, "This new set of graphic and text health warning templates will come into full effect on May 12, 2024."

 

Manufacturers, importers, distributors, and retailers of vaporized nicotine, nicotine-free, and new tobacco products who fail to comply with the graphic health warnings will face fines ranging from 2 million (34,591 USD) to 5 million (86,478 USD) Philippine pesos. The Department of Health stated that violators may also face up to six years in prison and have their licenses revoked. Without proper graphic health warnings, the Bureau of Internal Revenue may also prohibit or seize vaporized nicotine and non-nicotine products. Foreign violators will also be deported for non-compliance with graphic health warning requirements.

 

The Health Department is urging the public to report any violations of the regulations on health warning requirements directly to the Ministry of Trade and Commerce.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
South Korea’s finance ministry to directly crack down on illegal high-nicotine vape liquids
South Korea’s finance ministry to directly crack down on illegal high-nicotine vape liquids
The report says South Korea’s Ministry of Economy and Finance (referred to as the finance ministry) will directly lead crackdowns on illegal distribution and “upward manipulation” of nicotine concentrations in liquid e-cigarettes, after cases of extremely high-strength nicotine liquids circulating at retail shops were highlighted.
Feb.28 by 2FIRSTS.ai
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT to Launch New Ploom Stick Variant “EVO Sakura Regular” Nationwide in Japan on April 6
JT said it will begin rolling out “EVO Sakura Regular,” a new product under the premium EVO brand for the heated tobacco brand Ploom, at convenience stores and tobacco retailers across Japan from April 6. The product has already been on sale since February 3 through the CLUB JT online shop and Ploom Shops nationwide.
Mar.13 by 2FIRSTS.ai
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
BAT faces London shareholder lawsuit over alleged disclosure failures tied to North Korea business
British American Tobacco is facing a shareholder lawsuit in London alleging it failed to properly disclose to markets information about breaches of U.S. sanctions linked to its North Korea-related business. BAT agreed in 2023 to pay more than $635 million to U.S. authorities after a subsidiary admitted conspiring to violate U.S. sanctions by selling tobacco products to North Korea and committing bank fraud from 2007 to 2017.
Mar.05 by 2FIRSTS.ai
Oklahoma DOC to allow inmates to buy nicotine vapes and pouches in 2026
Oklahoma DOC to allow inmates to buy nicotine vapes and pouches in 2026
Oklahoma’s Department of Corrections says it will begin allowing inmates to buy single-use nicotine vapes and nicotine pouches through prison canteens in 2026, framing the move as a strategy to reduce contraband-driven debts and prison violence. Officials say inmates will be barred from using personal nicotine products, the devices will be disposable and non-cartridge-based, and the program will be self-funded through inmate purchases rather than taxpayer money.
Feb.05 by 2FIRSTS.ai
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco (JT) has introduced the new Nordic Spirit nicotine pouch brand in Japan. The Cola Fizz Medium flavor began early sales on March 3, 2026 via the CLUB JT online shop, and will be rolled out sequentially from April 6 through nationwide channels including 7-Eleven, Lawson, and NewDays. The Berry Mix Medium flavor is expected to launch on CLUB JT around mid-March.
Mar.04 by 2FIRSTS.ai